U.S. Capital Markets Stock News

Why Amicus Therapeutics is on investors’ radar today Amicus Therapeutics (FOLD) has caught investor attention after recent performance data showed modest positive returns over the past month and past 3 months, prompting closer focus on how its rare disease portfolio supports the current valuation. See our latest analysis for Amicus Therapeutics. At a share price of $14.46, Amicus Therapeutics shows only modest short term share price returns. The 1 year total shareholder return of 100.83%...

Wondering if Choice Hotels International at around US$120 is offering good value today or if the easy money has already been made? This article walks through what the current price might actually be saying. The stock has recently shown mixed performance, with a 1.7% return over the last 7 days, 21.2% over 30 days and 24.9% year to date, set against a 3.9% decline over the past year and a 9.2% return over five years. Recent coverage has focused on how Choice Hotels International fits into the...

Essential Properties Realty Trust (EPRT) has kicked off Q1 2026 with total revenue of US$158.8 million, basic EPS of US$0.28 and net income of US$59.8 million, with management and investors also watching FFO of US$114.6 million and FFO per share of US$0.54 as key REIT metrics. Over the past year, the company has seen revenue move from US$129.4 million and basic EPS of US$0.30 in Q1 2025 to US$158.8 million and US$0.28 in the latest quarter, while trailing twelve month revenue reached US$590.7...

It's been a good week for Weatherford International plc ( NASDAQ:WFRD ) shareholders, because the company has just...

First American Financial (FAF) has followed up its earnings rebound with trailing 12‑month revenue of about US$7.5 billion and basic EPS of US$6.02, alongside year‑over‑year reported earnings growth of very roughly 4x and a net profit margin of 8.3% versus 2.1% a year earlier. The company has seen quarterly revenue move from US$1,406.1 million in Q3 2024 to US$1,685.1 million in Q4 2024 and then to US$2,049.7 million in Q4 2025, with basic EPS shifting from a loss of US$1.00 in Q3 2024 to...

Wondering if American Superconductor at around US$46.15 is still offering value or if the easy money has already been made? This article breaks down what the current price might really imply. The stock has seen sharp moves recently, with returns of 21.5% over 7 days, 43.3% over 30 days, 46.1% year to date and 129.3% over 1 year, along with a very large 3 year return that sits above 7x. These moves come as American Superconductor continues to attract attention from investors looking at power...

Kinder Morgan (KMI) opened 2026 with Q1 results that build on a solid recent run, with Q4 2025 revenue at US$4.5 billion and basic EPS of US$0.45 supported by net income of US$991 million. Over the past few quarters, revenue has moved from US$3.7 billion in Q3 2024 to US$4.0 billion in Q2 2025 and US$4.5 billion in Q4 2025, while basic EPS shifted from US$0.28 to US$0.32 and then to US$0.45. Together, these figures give you a clear sense of the recent earnings trajectory. With a trailing net...

If you are wondering whether Annaly Capital Management's share price still reflects fair value after a strong run, this article walks through what the current numbers may be saying about the stock. The stock last closed at US$22.43, with returns of 1.3% over 7 days, 6.4% over 30 days, a 2.1% decline year to date, 35.7% over 1 year, 70.0% over 3 years and 21.4% over 5 years. Recent coverage has focused on Annaly Capital Management's position within the mortgage REIT space and how interest...

Western Alliance Bancorporation (NYSE:WAL) addressed two significant fraud-related loan charge-offs in Q1 2026, which management believes helps clear legacy credit risk. The bank reported $5.6b in Q1 deposit growth and plans to shift from aggressive deposit gathering to a more balanced growth approach. These moves are intended to refine Western Alliance's risk management and funding profile following a period of strong deposit inflows. Western Alliance Bancorporation enters this shift with...

Investors may be wondering whether Cytokinetics at around US$65.48 is still offering value, or if most of the upside is already reflected in the price. The stock has returned 0.1% over the last week, 9.1% over the past 30 days, 6.1% year to date and 62.4% over the last year, with longer term returns of 73.0% over 3 years and 148.1% over 5 years. Recent coverage has focused on Cytokinetics as a biotech name that investors are watching closely, with attention on how its pipeline and...

Investors may be asking whether Centene's current share price reflects its true worth, or if the recent weakness could be setting up a more interesting entry point. Centene's stock closed at US$41.09, with a 5.4% gain over the last 7 days and a 24.6% gain over the last 30 days, while returns sit at a 1.7% decline year to date and a 33.3% decline over the past year. Recent news around Centene has focused on its position in managed care and healthcare services, as investors weigh how policy,...

Corpay Cross-Border, part of NYSE:CPAY, has entered a new partnership with Toulouse Football Club as the club's Official FX Supplier. The agreement extends Corpay's reach in European football, following its previously announced relationship with AC Milan. The deal focuses on supporting Toulouse FC's international payment and currency risk management needs. For readers tracking NYSE:CPAY, this Toulouse FC partnership adds another high profile sports relationship to Corpay's cross border...

Goosehead Insurance (GSHD) has just posted its latest update for Q1 2026, with recent quarterly numbers showing Q4 2025 revenue of US$105.1 million and basic EPS of US$0.50 on net income of US$12.4 million. Over the past reported periods, revenue has moved from US$77.8 million in Q3 2024 to US$93.7 million in Q4 2024 and then to US$105.1 million in Q4 2025, while basic EPS over the same snapshot has been US$0.31, US$0.60 and US$0.50 respectively. This gives a clearer sense of how the top line...

Q1 2026 results set the tone for Roper Technologies (ROP) Roper Technologies (ROP) opened Q1 2026 earnings season with Q4 2025 revenue of US$2,058.6 million and basic EPS of US$4.00, backed by net income of US$428.4 million. Over the last few quarters, the company has seen revenue move from US$1,764.6 million in Q3 2024 to US$2,058.6 million in Q4 2025, while basic EPS shifted from US$3.43 to US$4.00. This gives investors a clearer view of how the top line and EPS are trending into the latest...

Immunome plans to present full Phase 3 RINGSIDE trial data for varegacestat in desmoid tumor patients at the 2026 ASCO Annual Meeting. The company expects to file a New Drug Application with the FDA for varegacestat after the ASCO presentation. The update highlights progress toward a potential new treatment option for this rare soft tissue tumor. For investors tracking Immunome, ticker NasdaqCM:IMNM, this update centers on a late stage program that could influence the company’s future...

If you are wondering whether Molson Coors Beverage is attractively priced at around US$42.87, the key is understanding what you are getting for that share price today. The stock has been under pressure over longer periods, with a 23.6% decline over the last year and a 9.6% drop year to date, although it has risen 4.2% over the past month while slipping 2.9% in the last week. Recent news flow around Molson Coors has focused on its position in the beverage sector and how investors are weighing...

Betterware de México, S.A.P.I. de C.V. reported past first-quarter 2026 results with sales of MX$3,509.7 million, slightly above the prior year’s MX$3,499.15 million, and net income of MX$281.34 million versus MX$151.39 million. The sharp improvement in profit despite broadly flat revenue suggests the company has recently become more efficient in converting sales into earnings. Next, we’ll examine how this stronger profitability trend could influence Betterware de México’s investment...

Iridium Communications (IRDM) Q1 2026 earnings snapshot Iridium Communications (IRDM) has entered Q1 2026 with trailing 12 month revenue of US$871.7 million and basic EPS of US$1.07, backed by net income of US$114.4 million. The most recent reported quarter, Q4 2025, delivered revenue of US$212.9 million and basic EPS of US$0.24. Over the past six reported quarters, revenue has ranged between US$212.8 million and US$226.9 million, with quarterly basic EPS moving between US$0.21 and US$0.35...

If you are wondering whether Kimbell Royalty Partners at around US$14.59 still offers value, the key question is how its current price lines up with its fundamentals and cash flows. The units have returned 1.0% over the last 7 days, around flat at 0.5% over 30 days, and are up 21.3% year to date and 33.0% over the past year, which may have shifted how some investors view its risk and reward profile. Recent attention on Kimbell Royalty Partners has focused on its role in the US energy sector...

DuPont de Nemours (NYSE:DD) has set new 2035 Sustainability Goals centered on sustainable innovation, resilient operations, and community engagement. The company recently introduced an AI-enabled RO Operations Advisor tool aimed at optimizing industrial water treatment processes. DuPont also launched ultrapure fluid transfer assemblies aimed at biopharma manufacturing and healthcare production environments. For investors watching materials and specialty chemicals, these moves illustrate how...

The United States market has remained flat over the past week but has seen an impressive 30% rise over the past year, with earnings projected to grow by 16% annually. In this context, identifying stocks that are perceived as undervalued can be particularly appealing, especially when there is insider buying which may suggest confidence in their potential.

If you are wondering whether CMS Energy at around US$76.62 is priced attractively or asking too much for its future prospects, you are in the right place. The stock has seen a 1.9% decline over the last 7 days, a 1.7% return over the past month, and sits on 8.8% year to date and 6.5% over the last year. These figures will shape how you think about both upside potential and risk. Over the past three years CMS Energy has delivered a 34.9% return, and over five years the return stands at 39.6%...

The market has been flat over the last week, but it's up 30% over the past year, with earnings forecast to grow by 16% annually. For investors willing to explore beyond established giants, penny stocks can offer a unique blend of affordability and growth potential. Despite their vintage name, these smaller or newer companies can present compelling opportunities when backed by solid financials.

The United States market has experienced a flat trajectory over the past week, yet it has achieved an impressive 30% increase over the past year, with earnings projected to grow by 16% annually. In this dynamic environment, identifying dividend stocks that offer consistent income and potential for growth can be a strategic approach for investors seeking stability and returns.